27 related articles for article (PubMed ID: 18291548)
1. Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis
Sesarman A; Luput L; Rauca VF; Patras L; Licarete E; Meszaros MS; Dume BR; Negrea G; Toma VA; Muntean D; Porfire A; Banciu M
J Liposome Res; 2024 Feb; ():1-12. PubMed ID: 38379249
[TBL] [Abstract][Full Text] [Related]
2. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
Schiffelers RM; Metselaar JM; Fens MH; Janssen AP; Molema G; Storm G
Neoplasia; 2005 Feb; 7(2):118-27. PubMed ID: 15802017
[TBL] [Abstract][Full Text] [Related]
3. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.
Negrea G; Rauca VF; Meszaros MS; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Muntean D; Sesarman A; Banciu M
Front Pharmacol; 2022; 13():870347. PubMed ID: 35450036
[TBL] [Abstract][Full Text] [Related]
4. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
Rauca VF; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Mot AC; Rakosy-Tican E; Sesarman A; Banciu M
Sci Rep; 2021 Nov; 11(1):22102. PubMed ID: 34764332
[TBL] [Abstract][Full Text] [Related]
5.
Luput L; Licarete E; Drotar DM; Nagy AL; Sesarman A; Patras L; Rauca VF; Porfire A; Muntean D; Achim M; Tomuta I; Vlase L; Catoi C; Dragos N; Banciu M
J Cancer; 2018; 9(2):440-449. PubMed ID: 29344291
[No Abstract] [Full Text] [Related]
6. Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids.
Lühder F; Reichardt HM
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837059
[TBL] [Abstract][Full Text] [Related]
7. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
[TBL] [Abstract][Full Text] [Related]
8. Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.
Kroon J; Buijs JT; van der Horst G; Cheung H; van der Mark M; van Bloois L; Rizzo LY; Lammers T; Pelger RC; Storm G; van der Pluijm G; Metselaar JM
Prostate; 2015 Jun; 75(8):815-24. PubMed ID: 25663076
[TBL] [Abstract][Full Text] [Related]
9. Cytochromes p450 and skin cancer: role of local endocrine pathways.
Slominski AT; Zmijewski MA; Semak I; Zbytek B; Pisarchik A; Li W; Zjawiony J; Tuckey RC
Anticancer Agents Med Chem; 2014 Jan; 14(1):77-96. PubMed ID: 23869782
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels.
Yang C; Mariner PD; Nahreini JN; Anseth KS
J Control Release; 2012 Sep; 162(3):612-8. PubMed ID: 22902591
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer.
Gianella A; Jarzyna PA; Mani V; Ramachandran S; Calcagno C; Tang J; Kann B; Dijk WJ; Thijssen VL; Griffioen AW; Storm G; Fayad ZA; Mulder WJ
ACS Nano; 2011 Jun; 5(6):4422-33. PubMed ID: 21557611
[TBL] [Abstract][Full Text] [Related]
12. Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids.
Kluza E; Heisen M; Schmid S; van der Schaft DW; Schiffelers RM; Storm G; ter Haar Romeny BM; Strijkers GJ; Nicolay K
Angiogenesis; 2011 May; 14(2):143-53. PubMed ID: 21225337
[TBL] [Abstract][Full Text] [Related]
13. Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.
Lobatto ME; Fayad ZA; Silvera S; Vucic E; Calcagno C; Mani V; Dickson SD; Nicolay K; Banciu M; Schiffelers RM; Metselaar JM; van Bloois L; Wu HS; Fallon JT; Rudd JH; Fuster V; Fisher EA; Storm G; Mulder WJ
Mol Pharm; 2010 Dec; 7(6):2020-9. PubMed ID: 21028895
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.
Banciu M; Fens MH; Storm G; Schiffelers RM
J Control Release; 2008 Apr; 127(2):131-6. PubMed ID: 18291548
[TBL] [Abstract][Full Text] [Related]
15. Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
Banciu M; Metselaar JM; Schiffelers RM; Storm G
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):101-10. PubMed ID: 18602825
[TBL] [Abstract][Full Text] [Related]
16. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide.
Hofkens W; van den Hoven JM; Pesman GJ; Nabbe KC; Sweep FC; Storm G; van den Berg WB; van Lent PL
Int J Pharm; 2011 Sep; 416(2):493-8. PubMed ID: 21382459
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis.
van den Hoven JM; Hofkens W; Wauben MH; Wagenaar-Hilbers JP; Beijnen JH; Nuijen B; Metselaar JM; Storm G
Int J Pharm; 2011 Sep; 416(2):471-7. PubMed ID: 21440612
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
Banciu M; Metselaar JM; Schiffelers RM; Storm G
Neoplasia; 2008 Feb; 10(2):108-17. PubMed ID: 18283332
[TBL] [Abstract][Full Text] [Related]
19. MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate.
Cittadino E; Ferraretto M; Torres E; Maiocchi A; Crielaard BJ; Lammers T; Storm G; Aime S; Terreno E
Eur J Pharm Sci; 2012 Mar; 45(4):436-41. PubMed ID: 21896328
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
